CFSG
TGTX icon

Clark Financial Services Group’s TG Therapeutics TGTX Stock Holding History

Clark Financial Services Group’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,520
Closed -$584K – 122
2025
Q4 		$584K Sell
19,520
-480
-2% -$15.7K 0.31% 44
2025
Q3 		$723K Buy
20,000
+1,195
+6% +$39.4K 0.38% 34
2025
Q2 		$677K Sell
18,805
-460
-2% -$17.1K 0.42% 30
2025
Q1 		$760K Buy
19,265
+5,474
+40% +$184K 0.53% 26
2024
Q4 		$415K Sell
13,791
-81
-0.6% -$2.33K 0.32% 38
2024
Q3 		$324K Hold
13,872
– – 0.3% 45
2024
Q2 		$246K Sell
13,872
-39
-0.3% -$622 0.26% 49
2024
Q1 		$211K Sell
13,911
-445
-3% -$7.09K 0.25% 59
2023
Q4 		$246K Buy
14,356
+161
+1% +$1.87K 0.32% 47
2023
Q3 		$119K Buy
14,195
+1,860
+15% +$25.9K 0.16% 57
2023
Q2 		$306K Sell
12,335
-4,941
-29% -$128K 0.41% 40
2023
Q1 		$260K Sell
17,276
-550
-3% -$8.36K 0.38% 43
2022
Q4 		$211K Buy
17,826
+622
+4% +$4.51K 0.24% 54
2022
Q3 		$102K Buy
+17,204
New +$113K 0.11% 57
2022
Q1 		$143K Sell
15,018
-44
-0.3% -$509 0.1% 60
2021
Q4 		$286K Sell
15,062
-113
-0.7% -$2.93K 0.19% 58
2021
Q3 		$505K Buy
15,175
+146
+1% +$4.52K 0.39% 33
2021
Q2 		$583K Buy
15,029
+45
+0.3% +$1.77K 0.46% 31
2021
Q1 		$722K Buy
+14,984
New +$720K 0.61% 28
2020
Q2 		$75K Buy
+17,628
New +$284K 0.12% 53

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Clark Financial Services Group's TGTX Position: Q1 2026 in Review

Clark Financial Services Group sold out of TG Therapeutics (TGTX) in Q1 2026, closing a stake of 19,520 shares — an estimated $584K sold.

Clark Financial Services Group first reported a position in TGTX in Q2 2020 and held it in 20 quarters. The position peaked at $760K in Q1 2025. 364 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Clark Financial Services Group reported no remaining TG Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Clark Financial Services Group sold 19,520 TG Therapeutics shares in Q1 2026, an estimated $584K.
  • Clark Financial Services Group first reported a position in TG Therapeutics in Q2 2020 and held it in 20 quarters.
  • Clark Financial Services Group's TG Therapeutics position peaked at $760K in Q1 2025.
  • 364 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Clark Financial Services Group's 13F filing for Q1 2026, filed 7 May 2026.